Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Peter Kolkhof

ResearcherPublications, citations & collaboration network

Peter Kolkhof is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 176 works, 14,768 citations, an h-index of 52 and an i10-index of 92.

176
Works
14,768
Citations
52
h-index
92
i10-index

How has Peter Kolkhof's publication output changed over time?

ScholarIQpublication output · 2013–2024

Output grew0% over the shown period — from 1 works in 2013 to 1 in 2024.

1
1
1
2
3
1
1
1
20132014201520162020202120222024

What are the most-cited papers on Peter Kolkhof?

ScholarIQmost cited works
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
George L. Bakris, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luís M. Ruilope, Peter Rossing, Peter Kolkhof, Christina Nowack, Patrick Schloemer, Amer Joseph, Gerasimos Filippatos
New England Journal of Medicine. 20202,761 CitationsOPEN ACCESS
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
Rajiv Agarwal, Gerasimos Filippatos, Bertram Pitt, Stefan D. Anker, Peter Rossing, Amer Joseph, Peter Kolkhof, Christina Nowack, Martin Gebel, Luís M. Ruilope, George L. Bakris, FIDELIO-DKD and FIGARO-DKD investigators
European Heart Journal. 20211,234 CitationsOPEN ACCESS
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Scott D. Solomon, John J.V. McMurray, Muthiah Vaduganathan, Brian Claggett, Pardeep S. Jhund, Akshay S. Desai, Alasdair D Henderson, Carolyn S.P. Lam, Bertram Pitt, Michele Senni, Sanjiv J. Shah, Adriaan A. Voors, Faı̈ez Zannad, Imran Zainal Abidin, Marco A. Alcocer‐Gamba, J. Atherton, Johann Bauersachs, Changsheng Ma, Chern‐En Chiang, Ovidiu Chioncel, Vijay Chopra, Josep Comin-Colet, Gerasimos Filippatos, Cândida Fonseca, Grzegorz Gajos, Sorel Goland, Eva Gonçalvesová, Seok‐Min Kang, Tzvetana Katova, Mikhail Kosiborod, Gustavs Latkovskis, Alex Pui‐Wai Lee, Gerard C.M. Linssen, Guillermo Llamas-Esperón, Vyacheslav Mareev, Felipe A. Martínez, Vojtěch Melenovský, Béla Merkely, Savina Nodari, Mark C. Petrie, Clara Saldarriaga, José Francisco Kerr Saraiva, Naoki Sato, Morten Schou, Kavita Sharma, Richard W. Troughton, Jacob A. Udell, Heikki Ukkonen, Orly Vardeny, Subodh Verma, Dirk von Lewinski, Л. Г. Воронков, Mehmet Birhan Yılmaz, Shelley Zieroth, James Lay‐Flurrie, Ilse van Gameren, Flaviana Amarante, Peter Kolkhof, Prabhakar Viswanathan
New England Journal of Medicine. 2024767 CitationsOPEN ACCESS
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
George L. Bakris, Rajiv Agarwal, Juliana C.N. Chan, Mark E. Cooper, Ron T. Gansevoort, Hermann Haller, Giuseppe Remuzzi, Peter Rossing, Roland E. Schmieder, Christina Nowack, Peter Kolkhof, Amer Joseph, Alexander Pieper, Nina Kimmeskamp‐Kirschbaum, Luís M. Ruilope
JAMA. 2015699 CitationsOPEN ACCESS
Molecular mechanisms and therapeutic targets for diabetic kidney disease
Katherine R. Tuttle, Rajiv Agarwal, Charles E. Alpers, George L. Bakris, Frank C. Brosius, Peter Kolkhof, Jaime Uribarri
Kidney International. 2022655 CitationsOPEN ACCESS

Related on ScholarIQ

Bayer (United States)
Institution
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
Paper
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
Paper
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
Paper
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy
Paper
Molecular mechanisms and therapeutic targets for diabetic kidney disease
Paper
470M+ articles · free account